| Senior Principal Scientist |
Toranomon (NPKK Head Office) |
Japon |
Biomedical Research |
Pharma Research |
Recherche & Développement |
03 avril 2025 |
| Principal Scientist II |
Toranomon (NPKK Head Office) |
Japon |
Biomedical Research |
Pharma Research |
Recherche & Développement |
03 avril 2025 |
| Head, Patient Advocacy |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
CTS |
Communications & Public Affairs |
01 avril 2025 |
| Clinical Research Associate |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
31 mars 2025 |
| Manager, Product Brand Comms |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
CTS |
Communications & Public Affairs |
30 mars 2025 |
| Expert Regulatory Writer |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
27 mars 2025 |
| Senior Regulatory Writer |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
27 mars 2025 |
| Associate Director, Early Strategic Partnerships |
Toranomon (NPKK Head Office) |
Japon |
Biomedical Research |
Pharma Research |
BDL et planification stratégique |
25 mars 2025 |
| Senior Clinical Sciences Trial Leader |
Toranomon (NPKK Head Office) |
Japon |
Biomedical Research |
Pharma Research |
Recherche & Développement |
25 mars 2025 |
| Associate/Manager, MSL（Solid Tumor） |
Toranomon (NPKK Head Office) |
Japon |
International |
Innovative Medicines |
Recherche & Développement |
24 mars 2025 |
| Production Operator |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Opérations techniques |
24 mars 2025 |
| SCM expert |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Opérations techniques |
24 mars 2025 |
| Field Technical Expert (Radio Ligand Therapy) |
Toranomon (NPKK Head Office) |
Japon |
International |
Innovative Medicines |
Accès au marché |
23 mars 2025 |
| Senior Manager, BPA Operations |
Toranomon (NPKK Head Office) |
Japon |
Finance |
Universal Hierarchy Node |
Audit et Finance |
19 mars 2025 |
| Manager, RA CMC Manager Japan |
Toranomon (NPKK Head Office) |
Japon |
Development |
Innovative Medicines |
Recherche & Développement |
13 mars 2025 |
| Japan Program Head (Immunology) |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
13 mars 2025 |
| Japan Program Clinical Head |
Toranomon (NPKK Head Office) |
Japon |
Biomedical Research |
Universal Hierarchy Node |
Recherche & Développement |
13 mars 2025 |
| Country Head of Quality (Japan) |
Toranomon (NPKK Head Office) |
Japon |
Operations |
Innovative Medicines |
Qualité |
12 mars 2025 |
| Japan Program Head (Neuroscience & GTx) |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
12 mars 2025 |
| Senior Specialist, IT Information Security Compliance |
Toranomon (NPKK Head Office) |
Japon |
Operations |
CTS |
Technology Transformation |
06 mars 2025 |
| Senior Lead, New Product Planning & Launch Excellence |
Toranomon (NPKK Head Office) |
Japon |
Strategy & Growth |
Innovative Medicines |
Commercialisation |
06 mars 2025 |
| Manager, People and Culture Communications |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
CTS |
Communications & Public Affairs |
04 mars 2025 |
| Associate, Automation Engineer |
Sasayama |
Japon |
Operations |
|
Opérations techniques |
04 mars 2025 |
| Lead, RWE and Evidence Excellence |
Toranomon (NPKK Head Office) |
Japon |
International |
Innovative Medicines |
Recherche & Développement |
04 mars 2025 |
| Senior Lead, Cx Content Creation |
Toranomon (NPKK Head Office) |
Japon |
International |
Innovative Medicines |
Commercialisation |
17 février 2025 |
| Site HSE Head Commercial Operations Japan |
Tokyo (NPKK Sales) |
Japon |
Operations |
CTS |
Installations et administration |
16 février 2025 |
| Manager DDIT Strategic Business Partner |
Toranomon (NPKK Head Office) |
Japon |
Operations |
CTS |
Technology Transformation |
04 février 2025 |
| Business Partner |
Toranomon (NPKK Head Office) |
Japon |
People & Organization |
Universal Hierarchy Node |
Ressources humaines |
31 janvier 2025 |
| Lead, Pricing & Public Policy |
Toranomon (NPKK Head Office) |
Japon |
International |
Innovative Medicines |
Accès au marché |
28 janvier 2025 |
| Sr Manager, Executive Communications |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
CTS |
Communications & Public Affairs |
23 janvier 2025 |
| Sr Manager, Growth Strategy and Policy Communications |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
CTS |
Communications & Public Affairs |
23 janvier 2025 |
| Group Manager, Brand and Reputation |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
CTS |
Communications & Public Affairs |
23 janvier 2025 |
| Senior Business Analyst DDIT IM JP&APMA Analyst & Patient |
Toranomon (NPKK Head Office) |
Japon |
Operations |
CTS |
Technology Transformation |
22 janvier 2025 |
| Japan Program Manager |
Toranomon (NPKK Head Office) |
Japon |
Development |
Innovative Medicines |
Recherche & Développement |
08 janvier 2025 |
| Sr Manager / Manager, Global Program Regulatory Manager (GPRM) Japan |
Toranomon (NPKK Head Office) |
Japon |
Development |
Innovative Medicines |
Recherche & Développement |
05 janvier 2025 |
| MS&T Expansion Lead RLT Sasayama |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Opérations techniques |
16 décembre 2024 |
| Investigation Expert |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
16 décembre 2024 |
| Clinical Biospecimen Senior Scientist |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
03 décembre 2024 |
| Head Regulatory Writing |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
03 décembre 2024 |
| Associate or Manager, PHAD Japan |
Toranomon (NPKK Head Office) |
Japon |
Development |
Universal Hierarchy Node |
Recherche & Développement |
03 décembre 2024 |
| Customer Engagement Lead |
Toranomon (NPKK Head Office) |
Japon |
International |
Innovative Medicines |
Ventes |
03 décembre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |
| Quality Control Staff |
Sasayama |
Japon |
Operations |
Innovative Medicines |
Qualité |
18 octobre 2024 |